NeoDynamics Q3: No sales but important regulatory milestone - Redeye

Redeye lowers its fair value range for NeoDynamics following the continuous assessment of the company’s financial position and an increased WACC due to a higher risk-free rate. Net sales were, as expected, practically zero in the quarter, but with a US launch during Q1 2023 and commenced production in the EU, we believe next year entails improved growth opportunities.

Länk till analysen i sin helhet: https://www.redeye.se/research/864210/neodynamics-q3-no-sales-but-important-regulatory-milestone?utm_source=finwire&utm_medium=RSS